Search for: "Novartis Pharmaceuticals Inc"
Results 21 - 40
of 393
Sort by Relevance
|
Sort by Date
21 Jun 2022, 2:18 pm
Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. v. [read post]
23 May 2022, 8:02 am
“Novartis’ DQ Bid Sinks In Gilenya Row” — “A federal judge in Delaware has rejected a legal effort to prevent a Washington, D.C., patent lawyer from representing an Indian pharmaceutical company in a patent fight with Novartis over the blockbuster multiple sclerosis drug Gilenya. [read post]
16 May 2022, 12:16 pm
Level of Possession for WD negative claim limitations: Novartis Pharmaceuticals v. [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
14 Mar 2022, 2:46 pm
See, e.g., Novartis Pharms. [read post]
27 Jan 2022, 5:56 am
This week’s newest patent applications are from Integrated Solution for Systems Inc, Novartis, Abbott, Roche, Medtronic, Merck, Boston Scientific, Mastercard, IBM, Apple, Microsoft, and Intel. [read post]
4 Jan 2022, 8:39 pm
This is a question that comes readily to mind when reading the Federal Circuit's opinion (and Chief Judge Moore's dissent) in Novartis Pharmaceuticals Corp. v. [read post]
12 Dec 2021, 2:22 pm
Novartis Pharms. [read post]
17 Sep 2021, 10:37 am
Just last year, pharmaceutical giant Novartis paid $678 million to settle allegations that in paid doctors inflated “speaking fees” and offered other incentives to induce them to prescribe their drugs to patients. [read post]
20 Aug 2021, 12:15 pm
In April 2013 a so-called “Dear Doctor” letter was sent out in Canada by Novartis Pharmaceuticals Canada Inc. warning about some serious side effects associated with Tasigna and a drug label change with new information concerning those leukemia drug Tasigna side effects. [read post]
5 Aug 2021, 12:12 pm
(collectively, GSK) sued Teva Pharmaceuticals USA, Inc. in the United States District Court for the District of Delaware for infringement of claims of GSK’s Reissue Patent No. [read post]
26 Apr 2021, 7:42 am
Novartis AG is working with Pfizer Inc. to fill vials quicker and to develop the mRNA needed for a new vaccine candidate produced by CureVA NV. [read post]
27 Jan 2021, 11:07 am
Badboy pharmaceutical giant Novartis AG and two of its subsidiaries paid the DOJ and SEC $346.7 million. [read post]
14 Jan 2021, 4:40 pm
A $145 million settlement with EHR provider Practice Fusion, Inc., which was alleged to have accepted kickbacks from pharmaceutical companies including Purdue Pharma in exchange for implementing prompts in its EHR system that were designed to increase prescriptions of specific drugs. [read post]
11 Sep 2020, 7:06 am
The U.S. government filed a False Claims Act case against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
3 Aug 2020, 7:02 am
Where there are specialists with a focus on the kind of work with which a patent is concerned, they are the relevant addressees of the patent and their specialist skills are attributed to the notional skilled person, even if the patent might also be of a broader application and of interest to non-specialists (Medimmune Ltd v Novartis Pharmaceuticals UK Ltd [2013] RPC 27). [read post]
5 May 2020, 9:37 pm
Novartis Pharmaceuticals Corp. [read post]
3 May 2020, 9:10 pm
Novartis Pharmaceuticals Corp. [read post]
28 Apr 2020, 11:46 pm
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
24 Apr 2020, 5:24 am
(collectively, Apotex) filed a petition for inter partes reviewof Novartis Pharmaceuticals Corporation’s U.S. [read post]
